# Randomized Trial Comparing Colesevelam vs. Ezetimibe

> **NCT02682680** · PHASE4 · COMPLETED · sponsor: **LMC Diabetes & Endocrinology Ltd.** · enrollment: 200 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Colesevelam
- **DRUG:** Ezetimibe

## Key facts

- **NCT ID:** NCT02682680
- **Lead sponsor:** LMC Diabetes & Endocrinology Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-11
- **Primary completion:** 2017-05-25
- **Final completion:** 2017-05-25
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2019-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02682680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02682680, "Randomized Trial Comparing Colesevelam vs. Ezetimibe". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02682680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*